Human PSMD2/P97/ RPN1 ORF/cDNA clone-Adenovirus plasmid (NM_002808)

Pre-made Human PSMD2/P97/ RPN1 adenoviral expression plasmid for PSMD2 adenovirus packaging, PSMD2 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

Target products collectionGo to PSMD2/P97 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)



Product information

Catalog No. Product Name Plasmid Grade Plasmid quantity
pGMAD000148 Human PSMD2 Adenovirus plasmid Research Grade 10mg, 50mg, 100mg, 500mg, >1g
GMP-like Grade 10mg, 50mg, 100mg, 500mg, >1g
High Quality (HQ) Grade
Seed 5ug


Product Description

Catalog ID pGMAD000148
Gene Name PSMD2
Accession Number NM_002808
Gene ID 5708
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 2727 bp
Gene Alias P97, RPN1, S2, TRAP2
Fluorescent Reporter EGFP
Mammalian Cell Selection
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE0437-Ab Anti-PSMD2/ P97/ RPN1 functional antibody
    Target Antigen GM-Tg-g-SE0437-Ag PSMD2 protein
    ORF Viral Vector pGMLV001099 Human PSMD2 Lentivirus plasmid
    ORF Viral Vector pGMAD000148 Human PSMD2 Adenovirus plasmid
    ORF Viral Vector pGMAD000442 Human PSMD2 Adenovirus plasmid
    ORF Viral Vector vGMLV001099 Human PSMD2 Lentivirus particle
    ORF Viral Vector vGMAD000148 Human PSMD2 Adenovirus particle
    ORF Viral Vector vGMAD000442 Human PSMD2 Adenovirus particle


    Target information

    Target ID GM-SE0437
    Target Name PSMD2
    Gene ID 5708, 21762, 705035, 287984, 101095190, 478654, 539784, 100059081
    Gene Symbol and Synonyms 9430095H01Rik,P97,PSMD2,RPN1,S2,TEG-190,Tex190,TRAP2
    Uniprot Accession Q13200
    Uniprot Entry Name PSMD2_HUMAN
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000175166
    Target Classification Not Available

    The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the non-ATPase subunits of the 19S regulator lid. In addition to participation in proteasome function, this subunit may also participate in the TNF signalling pathway since it interacts with the tumor necrosis factor type 1 receptor. A pseudogene has been identified on chromosome 1. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]



    About GMVC

    GDU



    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.